Drug recall · August 26, 2015
AMPICILLIN CAPSULES recall
Why: Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
AMPICILLIN CAPSULES, USP, 250 mg, 500 count bottles, Rx only, Manufactured for: DAVA Pharmaceuticals, Inc., Fort Lee, NJ, By: Suir Pharma Ireland Ltd., Clonmel, Ireland, NDC: 67253-180-50
- Lots / codes
Lot #: 52217, Expiry: 04/18
- Quantity
- 360 Bottles
- Company
- Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals, Huntsville, AL
- Distribution
- U.S. Including: OH
- Initiated
- August 13, 2015 · Voluntary: Firm initiated
- Classified
- August 20, 2015
- Reported
- August 26, 2015
- Ended
- August 21, 2015
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ampicillin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.